Genomcore strengthens its leadership in health data and digital innovation at Ennova Health Day 2025

Genomcore reaffirmed its position as a leading European company in health data management and digital transformation during the latest edition of Ennova Health Day, organised by Diario Médico and Correo Farmacéutico. The event highlighted a key sector priority: ensuring that healthcare innovation creates real value for system sustainability and improves patient outcomes.

A central theme across the sessions was the systemic rollout of artificial intelligence in clinical practice. As noted by Carlos Gallego, Director of Digital Health at the Sistema de Salut de Catalunya, the sector must “allow room for mistakes during early pilot projects but adopt a conservative approach during structured implementation”. This balance is essential to enable safe, scalable and impactful digital transformation.

Sector leaders echoed the need for a responsible and sustainable adoption of digital technologies. Nuria Ruiz Hombrebueno, Director General of Digitalisation of the Community of Madrid, stressed the importance of regulation and equity, while Bernardo Valdivieso, Regional Secretary for Digital Transformation of the Generalitat Valenciana, highlighted the need to ensure continuity and long-term viability of digital health projects. These principles directly align with Genomcore’s mission to build secure, efficient and long-lasting digital health infrastructures.

In this context, Miquel A. Bru Angelats, Genomcore’s Co-Founder & CBDO, took part in the panel “Innovating from within” alongside leading professionals from organisations such as VHIO and aptaTargets. Bru emphasised that Genomcore BIMS is far more than a technological platform: it is a strategic commitment to developing a robust multimodal health data ecosystem, ensuring that data generation, integration and processing are secure, interoperable and efficient for healthcare professionals and organisations across Europe.